Biotech Decoded

Biotech Decoded takes listeners behind the scenes of the biotechnology industry. Hosted by Yaron Werber, Biotechnology Analyst, Biotech Decoded looks at the intricacies of managing a successful biotech, from navigating mergers & acquisitions to discussing what it takes to be an effective biotech leader. Guests include management teams from leading biotechnology companies.

A woman in lab clothes uses a micropipette to fill test tubes.
You searched for
Biotech lab technicians studying test results on a computer and in a microscope.
Dec 23, 2024
Listen in as Praveen Tipirneni shares stories from his path to becoming Morphic's CEO, the company's sale and invaluable experience realized from his career in biotech.
Several businesswomen around a table having a meeting.
Nov 14, 2024
Jean Hynes discusses her career evolution to become CEO of Wellington Management. Listen to her two key pieces of advice for young women seeking to become a leader.
Two people working on business documents at a desk.
Aug 07, 2024
We hear from Jeff Solomon about his career in Wall Street and offers experience as an inspirational leader. He also shares insight about the state of biotech and the healthcare sector.
A lab technician using test tubes and a petri dish.
Jul 05, 2024
Are biotech investments in a long-term funk, a short-term slump or ready to rise again? Explore the investment strategy of Logos Capital and how the health care industry is adapting.
A man standing on a mountaintop looking at the landscape
Apr 03, 2024
Luke Timmerman discusses the Timmerman Traverse, which brings together biotech professionals who undertake climbs to benefit organizations battling cancer, poverty and sickle cell disease.
A scientist in a laboratory testing chemicals.
Feb 09, 2022
Gilead’s SVP of Corporate Development gives an insider's view of the deal-making process, including deal execution, oncology M&A trends, identifying acquisition targets, and negotiation insights.
A scientist in a laboratory testing chemicals
Oct 05, 2021
GV General Partner David Schenkein explores how external innovation helps large and small biotech companies succeed, "win-win" deals and how deal term structure facilitates effective collaborations.
A scientist in a laboratory testing chemicals.
Sep 28, 2021
Biotech industry leaders formerly of Celgene discuss collaboration, balancing internal/external innovation, and fostering partnerships through "deal-friendly" culture.